<p>Daniel Acker is a Principal at Flagship Pioneering and co-founder and chief innovation officer at Apriori Bio. He works in venture creation at the intersection of computational and experimental biology and has co-founded several start-ups within the Flagship ecosystem. Daniel earned a PhD in neuroscience at Brandeis University in the laboratory of Suzanne Paradis, where he studied structural synaptic plasticity, using molecular biology and electrophysiology to develop a novel therapeutic approach for epilepsy and using computational modeling to explore the effects of synaptic rewiring on memory. He also completed fellowships with Insight Data Science and NSF I-Corps. Prior to joining Flagship, Daniel worked as a data scientist at <a href="https://www.flagshippioneering.com/companies/repertoire-immune-medicines">Repertoire Immune Medicines</a> where he led a modeling group and designed statistical methods and data pipelines to decode T cell receptor specificities.</p>

large_Daniel Acker-new.jpg

Daniel Acker, PhD

Co-Founder and Chief Innovation Officer, Apriori Bio

Principal, Flagship Pioneering